Citadel Advisors’s Churchill Capital Corp VI Warrants, each exercisable for one share of Class A common stock at an exercise price of $11.50 per share CCVI.WS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q2
Sell
-200,000
Closed -$126K 14501
2022
Q1
$126K Hold
200,000
﹤0.01% 12043
2021
Q4
$205K Sell
200,000
-254
-0.1% -$289 ﹤0.01% 11799
2021
Q3
$240K Sell
200,254
-262
-0.1% -$347 ﹤0.01% 11574
2021
Q2
$281K Buy
+200,516
New +$271K ﹤0.01% 11421

Other funds holding CCVI.WS

Citadel Advisors's CCVI.WS Position: Q2 2022 in Review

Citadel Advisors sold out of Churchill Capital Corp VI Warrants, each exercisable for one share of Class A common stock at an exercise price of $11.50 per share (CCVI.WS) in Q2 2022, closing a stake of 200,000 shares — an estimated $126K sold.

Citadel Advisors first reported a position in CCVI.WS in Q2 2021 and held it in 4 quarters. The position peaked at $281K in Q2 2021. 45 funds tracked by Wall St. Rank hold CCVI.WS as of Q2 2022.

  • Citadel Advisors reported no remaining Churchill Capital Corp VI Warrants, each exercisable for one share of Class A common stock at an exercise price of $11.50 per share position as of Q2 2022 after selling out during the quarter.
  • Citadel Advisors sold 200,000 Churchill Capital Corp VI Warrants, each exercisable for one share of Class A common stock at an exercise price of $11.50 per share shares in Q2 2022, an estimated $126K.
  • Citadel Advisors first reported a position in Churchill Capital Corp VI Warrants, each exercisable for one share of Class A common stock at an exercise price of $11.50 per share in Q2 2021 and held it in 4 quarters.
  • Citadel Advisors's Churchill Capital Corp VI Warrants, each exercisable for one share of Class A common stock at an exercise price of $11.50 per share position peaked at $281K in Q2 2021.
  • 45 funds tracked by Wall St. Rank held Churchill Capital Corp VI Warrants, each exercisable for one share of Class A common stock at an exercise price of $11.50 per share as of Q2 2022.

Based on Citadel Advisors's 13F filing for Q2 2022, filed 15 Aug 2022.